EUCTR2004-000996-33-IT进行中（未招募）不适用
A Global Phase IV, Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate the Effectiveness of Detrusitol SR 4mg on Patient`s Perception of Bladder Condition (PPBC).
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- PFIZER
- 入组人数
- 730
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A global phase IV, double-blind, placebo-controlled, randomized trial to evaluate the effectiveness of Detrusitol SR 4 mg on Patient's Perception of Bladder Condition (PPBC). - N/AOveractive bladder syndrome (OAB)EUCTR2004-000996-33-SEPfizer AB600
进行中（未招募）
1 期
A global phase IV, double-blind, placebo-controlled, randomized trial to evaluate the effectiveness of Detrusitol SR 4 mg on Patient's Perception of Bladder Condition (PPBC). - N/AOveractive bladder syndrome (OAB)EUCTR2004-000996-33-DKPfizer ApS600
进行中（未招募）
1 期
A global phase IV, double-blind, placebo-controlled, randomized trial to evaluate the effectiveness of Detrusitol SR 4 mg on Patient's Perception of Bladder Condition (PPBC). - N/AOveractive bladder syndrome (OAB)EUCTR2004-000996-33-GBPfizer Global Pharmaceuticals, Pfizer Inc.600
进行中（未招募）
不适用
Pancreatic enzyme replacement therapy (PERT) in subjects with pancreatic exocrine insufficiency (PEI) after acute necrotizing pancreatitisEUCTR2013-005310-35-ESFundación para la Investigación en Enfermedades del Aparato Digestivo
进行中（未招募）
不适用
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Two-Phase Crossover Study of the Metabolic Impact of Tenofovir Disoproxil Fumarate on HIV 1 Seronegative Healthy Adult MalesEUCTR2004-005083-25-GBGilead Sciences Incorporated